Preventix: Funding, Investors & Team (Sep 2026)
Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally invasive approach to detect cervical cancer early on. Rather than collecting cervical cells like the Pap smear, Preventix looks for certain biomarkers in the blood that signal inflammation or abnormalities in the cervix. By analyzing a comprehensive 53-element blood chemistry panel, the test can identify signs of inflammation or potential precancerous developments.
Preventix has raised $3.5M across 1 funding round on record, the most recent a Seed of $3.5M announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Preventix Company Profile and Key Stats
Latest funding round on record: May 2025.
Preventix Funding Rounds
Preventix Founders and Leadership Team
No contact details are on record for this team yet.
Preventix Funding Compared to Other Biotechnology Startups
Preventix's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Preventix in Biotechnology and Torres
Companies Similar to Preventix
Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Preventix Funding FAQs
What does Preventix do?
Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally invasive approach to detect cervical cancer early on. Rather than collecting cervical cells like the Pap smear, Preventix looks for certain biomarkers in the blood that signal inflammation or abnormalities in the cervix. By analyzing a comprehensive 53-element blood chemistry panel, the test can identify signs of inflammation or potential precancerous developments.
How much funding has Preventix raised?
Preventix has raised $3.5M across 1 round on record. The most recent is a Seed of $3.5M announced in May 2025.
When did Preventix last raise funding?
Preventix's most recent funding round on record is a Seed of $3.5M, announced in May 2025.
Who founded Preventix?
FundedIQ lists Davide Gandus (Founder) at Preventix.
Where is Preventix headquartered?
Preventix is based in Torres, Pangasinan, Philippines.
How many employees does Preventix have?
Preventix is in the 1-10 employee band.
How does Preventix's funding compare to other Biotechnology startups?
Preventix's latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Preventix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Preventix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.